Natco Pharma competitive analysis

Explore patent oppositions filed by Natco Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Pharmaceutical Formulation Comprising Lanthanum CompoundsSHIRE BIOPHARMACEUTICALS IRELANDMar 23, 2017

Explore Natco Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jun 28, 2023Novel Polymorphic Form Of Imatinib Mesylate And A Process For Its Preparation2
Apr 24, 2019Anhydrous Lenalidomide Form-I2

Latest PTAB cases involving Natco Pharma

Discover the latest PTAB cases involving Natco Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Natco Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NATCO PHARMA14 - -
ACAPO ONSAGERS8 - - -
GIZINSKA SCHOHE1 - - -
HOFFMANN EITLE191 - - -